Where do CG Oncology's ratios come from?

Every ratio is computed from CG Oncology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

CG Oncology CGON Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-4,239%+483pp	-4,722.1%+3,563pp	-8,285.3%+20,261pp	-28,546.1%-8,244pp	-20,302.3%-10,235pp
Net margin	-3,682.6%+302pp	-3,985%+2,983pp	-6,968%+16,277pp	-23,245.2%-7,300pp	-15,945.2%-8,216pp
Returns
Return on equity	-20.8%+0.9pp	-21.7%+3.1pp	-24.7%-3.8pp	-21%-4.4pp	-16.6%—
Return on invested capital	-24.9%+6.8pp	-31.7%-0.2pp	-31.5%-4.9pp	-26.6%-3.3pp	-23.2%—
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	31.3×+6.7×	24.6×+1.8×	22.8×+0.6×	22.2×-8.8×	31×-4.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$12.92+32.7%	$9.74+8.6%	$8.96+1.9%	$8.79-4.9%	$9.25-21.2%
Valuation
Market capitalization	$5.71B+70.6%	$3.35B+9.1%	$3.07B+56.2%	$1.97B+5.4%	$1.87B-14.5%
Price / sales	1,126.9×+298×	829×-584×	1,412.7×-2,156×	3,569.2×+750×	2,819.6×+903×
Price / book	5.2×+0.8×	4.5×0.0×	4.5×+1.5×	2.9×+0.3×	2.6×-0.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do CG Oncology's ratios come from?: Every ratio is computed from CG Oncology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.